De nove Philadelphia chromosome-positive myelodysplastic syndromes with complex karyotype and p230 BCR::ABL fusion transcript: a case report with a literature review

References

• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544.
   PubMed Web of Science ®Google Scholar
• Brunning RD, Orazi A, Germing U, et al. Myedysplastic syndromes/neoplasms, overview. In: Swerdlow, editor. WHO classification of tumours of haematopoietic and lymphoid tissues, ed 4.Lyon. Lyon: IARC press; 2008. p. 88–93.
   Google Scholar
• Steelman LS, Pohnert SC, Shelton JG, et al. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 2004;18(2):189–218. doi:10.1038/sj.leu.2403241.
   PubMed Web of Science ®Google Scholar
• Rana A, Ali GM, Ali S, et al. BCR-ABL1 in leukemia: disguise master outplays riding shotgun. J Cancer Res Ther. 2013;9(1):6–10. doi:10.4103/0973-1482.110339.
   PubMed Web of Science ®Google Scholar
• Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88(7):2375–2384. PMID: 8839828.
   PubMed Web of Science ®Google Scholar
• Chissoe SL, Bodenteich A, Yang YF, et al. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics. 1995;27(1):67–82. doi:10.1006/geno.1995.1008.
   PubMed Web of Science ®Google Scholar
• Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia. 1996;10(8):1283–1287. PMID: 8709632.
   PubMed Web of Science ®Google Scholar
• Khoury JD, Solary E, Abla O, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–1719. doi:10.1038/s41375-022-01613-1.
   PubMed Web of Science ®Google Scholar
• Kurt H, Zheng L, Kantarjian HM, et al. Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome. Mod Pathol. 2018;31(7):1141–1154. doi:10.1038/s41379-018-0014-x.
   PubMed Web of Science ®Google Scholar
• Mitelman F. ISCN 1995: an international system for human cytogenetic nomenclature 1995: recommendations of the international standing committee on human cytogenetic nomenclature. Memphis, Tennessee: Karger Medical and Scientific Publishers; 1995.
   Google Scholar
• Dalla Torre CA, de Martino Lee ML, Yoshimoto M, et al. Myelodysplastic syndrome in childhood: report of two cases with deletion of chromosome 4 and the Philadelphia chromosome. Leuk Res. 2002;26(6):533–538. doi:10.1016/s0145-2126(01)00152-7.
   PubMed Web of Science ®Google Scholar
• Lesesve JF, Troussard X, Bastard C, et al. P190bcr/abl rearrangement in myelodysplastic syndromes:two reports and review of literature. Br J Haematol. 1996;95(2):372–375. doi:10.1046/j.1365-2141.1996.d01-1898.x.
   PubMed Web of Science ®Google Scholar
• Wakayama T, Maniwa Y, Ago H, et al. A variant form of myelodysplastic syndrome with Ph-minor-BCR/ABL transcript. Int J Hematol. 2001;74(1):58–63. doi:10.1007/BF02982550.
   PubMed Web of Science ®Google Scholar
• Keung YK, Beaty M, Powell BL, et al. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia—retrospective study and review of literature. Leuk Res. 2004;28(6):579–586. doi:10.1016/j.leukres.2003.10.027.
   PubMed Web of Science ®Google Scholar
• Roth DG, Tichman CM, Rowley JD. Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome. Blood. 1980;56(2):262–264. doi:10.1182/blood.v56.2.262.262.
   PubMed Web of Science ®Google Scholar
• Berrebi A, bruck R, Shtalrid M, et al. Philadelphia chromosome in idiopathic acquired sideroblastic anemia. Acta Haematol. 1984;72(5):343–345. doi:10.1159/000206412.
   PubMed Web of Science ®Google Scholar
• Ohyashiki K, Kocova M, Ryan DH, et al. Secondary acute myeloblastic leukemia with a Ph translocation in a treated wegener's granulomatosis. Cancer Genet Cytogenet. 1986;19(3-4):331–333. doi:10.1016/0165-4608(86)90062-2.
   PubMedGoogle Scholar
• Smadja N, Krulik M, Hagemeijer A, et al. Cytogenetic and molecular studies of the Philadelphia translocation t(9;22) observed in a patient with myelodysplastic syndrome. Leukemia. 1989;3(3):236–238. PMID: 2918760.
   PubMed Web of Science ®Google Scholar
• Larripa I, Gutierrez M, Giere I, et al. Complex karyotype with PH1 chromosome in myelodysplasia: cytogenetic and molecular studies. Leukemia and Lymphoma. 1992;6(4):401–406. doi:10.3109/10428199209053573.
   Web of Science ®Google Scholar
• Xue Y, Zhang R, Guo Y, et al. Acquired amegakaryocytic thrombocytopenic purpura with a Philadelphia chromosome. Cancer Genet Cytogenet. 1993;69(1):51–56. doi:10.1016/0165-4608(93)90113-z.
   PubMedGoogle Scholar
• Drummond MW, Lush CJ, Vickers MA, et al. Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome. Leukemia. 2003;17:463–465. doi:10.1038/sj.leu.2402814.
   PubMed Web of Science ®Google Scholar
• Dutta S, Kumari P, Natraj KS, et al. Philadelphia chromosome-positive myelodysplastic syndrome: Is It a distinct entity? Acta Haematol. 2013;129(4):215–217. doi:10.1159/000345263.
   PubMed Web of Science ®Google Scholar
• Seo BY, Lee JH, Kang MG, et al. Cryptic e1a2 BCR-ABL1 fusion with complex chromosomal abnormality in de novo myelodysplastic syndrome. Ann Lab Med. 2015;35(6):643–646. doi:10.3343/alm.2015.35.6.643.
   PubMed Web of Science ®Google Scholar
• Armas A, Chen C, Mims M, et al. Uncovering clinical features of De novo Philadelphia positive myelodysplasia. Case Rep Hematol. 2017: 5404131. doi:10.1155/2017/5404131.
   PubMedGoogle Scholar
• Katalinic D. De novo Philadelphia chromosome (BCR/ABL1) positive myelodysplastic syndrome: is it a distinct molecular and clinical entity? Indian J Hematol Blood Transfus. 2018;34(2):365–367. doi:10.1007/s12288-017-0857-1.
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Liu RT, Pan JQ, et al. Myelodysplastic syndrome with chromosome 5q deletion and Philadelphia chromosome: case report and literatures review. Chinese J Hematol. 2020;41(11):940–942. doi:10.3760/cma.j.issn.0253-2727.2020.11.011.
   Google Scholar
• Rahman K, Singh MK, Gupta R, et al. De novo Philadelphia chromosome positive myelodysplastic syndrome: report of two cases with brief literature review. J Cancer Res Ther. 2020;16(1):173–176. doi:10.4103/0973-1482.188428.
   PubMed Web of Science ®Google Scholar
• Onozawa M, Fukuhara T, Takahata M, et al. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL. Ann Hematol. 2003;82(9):593–595. doi:10.1007/s00277-003-0703-4.
   PubMed Web of Science ®Google Scholar
• Chelapareddy LR, Sen S. Philadelphia translocation in MDS: a case report and a brief review of the literature looking at its prevalence, disease progression, and treatment options. Case Rep Hematol. 2018: 5865321. doi:10.1155/2018/5865321.
   PubMed Web of Science ®Google Scholar
• Reap L, Goldman L. Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia. Leuk Res Rep. 2020;14:100225. doi:10.1016/j.lrr.2020.100225.
   PubMedGoogle Scholar
• Dastugue N, Demur C, Paris F, et al. Association of the Philadelphia chromosome and 5q in secondary blood disorders. Cancer Genet Cytogenet. 1988;30(2):253–259. doi:10.1016/0165-4608(88)90192-6.
   PubMedGoogle Scholar
• Veorhoef G, Meeus P, Stul M, et al. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Cancer Genet Cytogenet. 1992;59(2):161–166. doi:10.1016/0165-4608(92)90209-q.
   PubMedGoogle Scholar
• Zhang L, Bennett JM, Zhang X, et al. Uncommon of the uncommon: low-grade myelodysplastic syndrome evolving into chronic myelogenous leukemia. J Clin Oncol. 2011;29(15):434–436. doi:10.1200/JCO.2010.31.6265.
   Web of Science ®Google Scholar
• Zaslav AL, Gupta R, Burks BT, et al. Transformation of myelodysplastic syndrome with isolated 5q-syndrome to chronic myelogenous leukemia with a novel complex BCR/ABL1 translocation with rapid progression to blast crisis. Hematol Leuk. 2016, http://www.hoajonline.com/journals/pdf/2052-434X-4-2.pdf.
   Google Scholar
• Sheets JW, Eulitt P, He R, et al. Philadelphia chromosome-positive acute myeloid leukemia With e1a3 BCR-ABL1 fusion transcript. HemaSphere. 2020;4(6):484. doi:10.1097/HS9.0000000000000484.
   Web of Science ®Google Scholar
• Primo D, Tabernero MD, Rasillo A, et al. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities. Leukemia. 2003;17(6):1124–1129. doi:10.1038/sj.leu.2402963.
   PubMed Web of Science ®Google Scholar
• Low SK, Nanua S, Patel M, et al. AML with BCR-ABL1 fusion treated with imatinib, a hypomethylating agent and venetoclax. Leuk Res Rep. 2022;17:100333. doi:10.1016/j.lrr.2022.100333.
   PubMedGoogle Scholar
• Senapati J, Sasaki K. Chromosomal instability in chronic myeloid leukemia: mechanistic insights and effects. Cancers. 2022;14:2533. doi:10.3390/cancers14102533.
   PubMed Web of Science ®Google Scholar
• Bacher U, Haferlach T, Alpermann T, et al. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations. Br J Haematol. 2011;152(6):713–720. doi:10.1111/j.1365-2141.2010.08472.x.
   PubMed Web of Science ®Google Scholar
• Fukunaga A, Sakoda H, Iwamoto Y, et al. Abrupt evolution of Philadelphia chromosome-positive acute myeloid leukemia in myelodysplastic syndrome. Eur J Haematol. 2013;90(3):245–249. doi:10.1111/ejh.12056. Epub 2013 Jan 9.
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) V.1.2022. © National comprehensive cancer network, Inc. 2022. All rights reserved. To view the most recent and complete version of the guideline, go online to NCCN.org.
   Google Scholar